XAAR PLC

Director's Dealing • Oct 1, 2025

National Storage Mechanism | Additional information

RNS Number : 7019B

Xaar PLC

01 October 2025

1 October 2025

Xaar plc

Notification of Transactions of Directors and PDMRs

Xaar plc (the "Company") announces that the Director/Person Discharging Managerial Responsibilities ("PDMR") listed below has traded in the Company's ordinary 10 pence shares ("Shares") as follows:

Name of Director/ PDMR	Date of Transaction	Nature of Transaction	Share Price (£)	Number of Shares/Share Options
Dr Inken Braunschmidt (Non-Executive Director)	1 October 2025	Purchase of Shares	£1.28	4,000

The FCA notification, made in accordance with the requirements of the UK Market Abuse Regulation is appended below and gives further details on the transactions described above. 

This notification is made in accordance with DTR 3.1.4 R(1).

Enquiries:

Xaar plc	+44 (0)1223 423 663
Julia Crane, Company Secretary	[email protected]

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Dr Inken Braunschmidt
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Xaar plc
b)	LEI	213800MXEC3KAOBBPO57
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 10 pence each
Identification code	GB0001570810
b)	Nature of the transaction	Purchase of Shares
c)	Price(s) and volume(s)
		Price(s)	Volume(s)
		£1.28	4,000
d)	Aggregated information
- Aggregated volume	4,000
- Price	£5,120.00
e)	Date of the transaction	1 October 2025
f)	Place of the transaction	London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFSEIRLLIIE